Live feed
Filing
SC 13D/A
SC 13D/A0001387131-22-000438·Fusion Pharmaceuticals Inc.
Schedule 13D ownership disclosure
FUSION PHARMACEUTICALS INC
Security class unavailable · CUSIP: 36118A100
Event date: 2022-01-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,621,436
- Percent of class
- 6.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-22-000438
- Form type
- SC 13D/A
- Filer
- Fusion Pharmaceuticals Inc.
- CIK
- CIK 1805890
- Filed
- Jan 18, 2022
- Reporting period
- Jan 12, 2022
- Description
- Schedule 13D beneficial ownership